Revolutionizing cancer treatment with bacteria

Introduction to targeted chemotherapy

Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy cells, and limited effectiveness. However, a groundbreaking approach developed by researchers at the National University of Singapore (NUS) offers a more precise, potent, and less harmful alternative. This innovative method significantly enhances treatment efficacy while reducing the required drug dosage, marking a substantial advancement in cancer therapy.

Engineered bacteria as drug delivery agents

At the forefront of this revolutionary treatment are engineered bacteria that deliver chemotherapy drugs directly to tumor sites. Utilizing the natural interactions between bacteria and cancer cells, this method ensures that the drugs are activated only within the tumor environment. This targeted approach minimizes damage to healthy tissues and enhances the effectiveness of the treatment.

Prodrug strategy and bacterial innovation

The engineered bacteria carry a prodrug that converts to the active chemotherapy drug SN-38 at the tumor site. In preclinical models of nasopharyngeal cancer, these bacteria localized specifically in the tumor, releasing the drug directly where it is most needed. This resulted in a 67% reduction in tumor growth and a 54% increase in the effectiveness of the chemotherapy drug.

Potential for wider cancer treatment applications

One of the most promising aspects of this research is its potential application across various types of cancer. The Lactobacillus strain used in the study binds specifically to cancer cells, suggesting that this method could be adapted to target multiple mucosal cancers, such as colorectal, bladder, stomach, oral, lung, and nasal cancer. This versatility could lead to the development of a universal cancer treatment platform.

Conclusion

The development of prodrug-conjugated tumor-seeking commensals represents a significant step forward in the fight against cancer. By offering a targeted and less toxic approach to chemotherapy, this method holds the promise of improving the quality of life for cancer patients and potentially increasing long-term survival rates. The ongoing research and development in this field continue to push the boundaries of what is possible in cancer treatment.

Source